Injectable peptides are the new anti-aging trend sweeping the beauty industry. These compounds are promoted on social media ...

Add Yahoo as a preferred source to see more of our stories on Google. If you’re considering a semaglutide medication like Ozempic or Wegovy for weight loss, you may be a bit worried about the weekly ...

Alembic Pharmaceuticals secures USFDA approval for generic Methotrexate injection, boosting its oncology portfolio and strengthening its presence in the US generics market.

Skyrizi is used to treat autoimmune and inflammatory conditions like Crohn’s disease and plaque psoriasis. It is administered via intravenous injection by a healthcare professional or subcutaneous ...

Injectable peptides are the new anti-aging trend sweeping the beauty industry. These compounds are promoted on social media ...

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Semaglutide, the active ingredient in Ozempic and Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist taken as a once-weekly ...

Semaglutide (Ozempic®, Wegovy®, Rybelsus®) comes in both injection and oral form. But beyond how you take it, what’s the difference? And which form is more effective for weight loss? Semaglutide ...

Stelara (ustekinumab) is a brand-name prescription drug approved to treat Crohn’s disease, ulcerative colitis, plaque psoriasis, and psoriatic arthritis. You should always administer Stelara according ...

PHILADELPHIA, Pa. – Around the world there are more than 100 safe injection sites, in countries like Canada, Australia and Spain. However, in the U.S. there are none. “In 2017, 1,217 Philadelphians ...

Research from North Carolina State University found an injectable particle could help reduce blood loss in infants during ...

While GLP-1 weight loss meds have been a mainstay in pop culture for a few years now, they're potentially about to get even more widespread. Formerly only available as an injection, Wegovy recently ...

Spain becomes first in the EU to fund HIV prevention injection, with rollout starting in 2026 through public healthcare.